SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-006381
Filing Date
2023-04-21
Accepted
2023-04-21 08:23:00
Documents
13
Period of Report
2023-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K azyo-20230420x8k.htm   iXBRL 8-K 51895
2 EX-99.1 azyo-20230420xex99d1.htm EX-99.1 10859
  Complete submission text file 0001558370-23-006381.txt   194554

Data Files

Seq Description Document Type Size
3 EX-101.SCH azyo-20230420.xsd EX-101.SCH 3125
4 EX-101.LAB azyo-20230420_lab.xml EX-101.LAB 16581
5 EX-101.PRE azyo-20230420_pre.xml EX-101.PRE 10451
7 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20230420x8k_htm.xml XML 5060
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 23834639
SIC: 2836 Biological Products, (No Diagnostic Substances)